Proteolipid protein gene expression in demyelination and remyelination of the central nervous system: A model for multiple sclerosis

Journal of Neuropathology and Experimental Neurology

Volumn 53, Issue 2, 1994, Pages 136-143

  Rodriguez, Moses ^a   Prayoonwiwat, Naraporn ^a   Howe, Charles ^a   Sanborn, Kathleen ^a  

^a MAYO CLINIC   (United States)

Author keywords

Glia; Multiple sclerosis; Myelin; Oligodendrocyte; Picornavirus; Theiler s virus; TMEV

Indexed keywords

ACTIN; MESSENGER RNA; PROTEOLIPID PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN INFECTION; CONTROLLED STUDY; DEMYELINATION; FEMALE; GENE EXPRESSION REGULATION; IMMUNOCYTOCHEMISTRY; IN SITU HYBRIDIZATION; MOUSE; MULTIPLE SCLEROSIS; MURINE ENCEPHALOMYELITIS VIRUS; NONHUMAN; PRIORITY JOURNAL; PROTEIN INDUCTION; REMYELINIZATION;

ANIMALS; DISEASE MODELS, ANIMAL; FEMALE; GENE EXPRESSION; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MICE; MICE, INBRED C57BL; MICE, INBRED STRAINS; MULTIPLE SCLEROSIS; MYELIN PROTEINS; MYELIN PROTEOLIPID PROTEIN; MYELIN SHEATH; POLIOMYELITIS; RNA, MESSENGER; SPINAL CORD; THEILOVIRUS; TIME FACTORS;

EID: 0028256219     PISSN: 00223069     EISSN: 15546578     Source Type: Journal    
DOI: 10.1097/00005072-199403000-00004     Document Type: Article

References (45)

1. Campagnoni AT. Molecular biology of myelin proteins from the central nervous system. J Neurochem 1988; 51: 1-14
2. Trapp BD, Moench T, Pulley M, Barboase E, Tennekoon G, Griffin J. Spatial segregation of mRNA encoding myelin-specific proteins. Proc Natl Acad. Sci USA 1987; 84: 7773-7
3. Jordan C, Friedrich V Jr, Dubois-Dalcq M. In situ hybridization analysis of myelin gene transcripts in developing mouse spinal cord. JNeurosci 1989; 9: 248-57
4. Verity AN, Campagnoni AT. Regional expression of myelin protein genes in the developing mouse brain: In situ hybridization studies. J Neurosci Res 1988; 21: 238-48
5. Shiota C, Miura M, Mikoshiba K. Developmental profile and differential localization of mRNAs of myelin proteins (MBP and PLP) in oligodendrocytes in the brain and in culture. Brain Res Dev Brain Res 1989; 45: 83-94
6. Levine SM, Wong D, Macklin WB. Developmental expression of proteolipid protein and DM20 mRNAs and proteins in the rat brain. Dev Neurosci 1990; 12: 235-50
7. Jordan CA, Friedrich VL Jr, Godfraind C, Cardellechio CB, Holmes KV, Dubois-Dalcq M. Expression of viral and myelin gene transcripts in a murine CNS demyelinating disease caused by a coro-navirus. GLIA 1989; 2: 318-29
8. Kristensson K, Holmes KV, Duchala CS, Zeller NK, Lazzarin RA, Dubois-Dalcq M. Increased levels of myelin basic protein transcript gene in virus-induced demyelination. Nature 1986; 322: 544-7
9. Yamada M, Zurbriggen A, Fujinami RS. The relationship between viral RNA, myelin-specific mRNAs, and demyelination in central nervous system disease during Theiler’s virus infection. Am J Pathol 1990; 137: 1467-79
10. Ozden S, Aubert C, Gonzalez-Dunia D, Brahic M. In situ analysis of proteolipid protein gene transcripts during persistent Theiler’s virus infection. J Histochem Cytochem 1991; 39: 1305-9
11. Vermeesch MK, Knapp PE, SkofT RP, Studzinski DM, Benjamins JA. Death of individual oligodendrocytes in jimpy brain precedes expression of proteolipid protein. Dev Neurosci 1990;12: 303-15
12. Dubois-Dalcq M, Armstrong R. The cellular and molecular events of central nervous system remyelination. Bioessays 1990; 12: 569-76
13. Rodriguez M, Oleszak E, Leibowitz J. Theiler’s murine encephalomyelitis: A model of demyelination and persistence of virus. Crit Rev Immunol 1987; 7: 325-66
14. Rodriguez M, Leibowitz JL, Lampert PW. Persistent infection of oligodendrocytes in Theiler’s virus-induced encephalomyelitis. Ann Neurol 1983; 13: 426-33
15. Aubert C, Chamorro M Brahic M. Identification of Theiler’s virus infected cells in the central nervous system of mouse during demyelinating disease. Microb Pathog 1987; 3: 319-26
16. Welsh CJR, Tonks P, Nash AA, Blakemore WF. The effect of L3T4 T cell depletion on the pathogenesis of Theiler’s murine encephalomyelitis virus infection in CBA mice. J Gen Virol 1987; 68: 1659-67
17. Clatch RJ, Lipton HL, Miller SD. Characterization of Theiler’s murine encephalomyelitis virus (TMEV)-specific delayed type hypersensitivity responses in TMEV-induced demyelinating disease: Correlation with clinical signs. J Immunol 1986; 136: 920-7
18. Rodriguez M, Sriram S. Successful therapy of Theiler’s virus-induced demyelination (DA strain) with monoclonal anti Lyt2 antibody. J Immunol 1988; 140: 2950-5
19. Borrow P, Tonks P, Welsh CJ, Nash AA. The role of CD8+ T cells in the acute and chronic phases of Theiler’s murine encephalomyelitis virus-induced disease in mice. J Gen Virol 1992; 73: 1861-5
20. Rodriguez M, Pease LR, David CS. Immune-mediated injury of virus-infected oligodendrocytes: A model of multiple sclerosis. Immunol Today 1986; 7: 359-63
21. Rodriguez M. Virus-induced demyelination in mice: "Dying back" of oligodendrocytes. Mayo Clin Proc 1985; 60: 433-8
22. Rodriguez M, Scheithauer BW, Forbes G, Kelly PJ. Oligodendrocyte injury is an early event in lesions of multiple sclerosis. Mayo Clin Proc 1993; 68: 627-36
23. Rodriguez M. Central nervous system demyelination and remyelination in multiple sclerosis and viral models of disease. J Neu-roimmunol 1992; 40: 255-64
24. Ludwin SK, Johnson ES. Evidence for a "dying-back" gliopathy in demyelinating disease. Ann Neurol 1981; 9: 301-5
25. Spencer PS, Schaumburg HH. Central-peripheral distal axonopathy: The pathology of dying-back polyneuropathies. Prog Neuro-pathol 1976; 3: 253-95
26. Brahic M, Haase AT, Cash E. Simultaneous in situ detection of viral RNA and antigens. Proc Natl Acad Sci USA 1984; 81: 5445-8
27. Patick AK, Lindsley MD, Rodriguez M. Differential pathogenesis in oligodendrocytes in the brain and in culture. Brain Res Dev Brain Res 1989; 45: 83-94
28. Rodriguez M, Lennon V, Benveniste EN, Merrill JE. Remyelination by oligodendrocytes stimulated by antiserum to spinal cord. J Neu-ropathol Exp Neurol 1987; 46: 84-95
29. Rodriguez M, Lennon VA. Immunoglobulins promote remyelination in the central nervous system. Ann Neurol 1990; 27: 12-17
30. Rodriguez M, Pierce ML, Thiemann RL. Immunoglobulins stimulate central nervous system remyelination: Electron microscopic and morphometric analysis of proliferating cells. Lab Invest 1991; 64: 358-70
31. Patick AK, Thiemann RL, O’Brien PC, Rodriguez M. Persistence of Theiler’s virus infection following promotion of central nervous system remyelination. J Neuropathol Exp Neurol 1991; 50: 523-37
32. Puckett C, Hudson L, Ono K, et al. Myelin-specific proteolipid protein is expressed in myelinating Schwann cells but is not incorporated into myelin sheaths. J Neurosci Res 1987; 18:511-18
33. Minty AJ, Alonso S, Guenet JL, Buckingham ME. Number and organization of actin-related sequences in the mouse genome. J Mol Biol 1983; 167: 77-101
34. Ozden S, Aubert C, Gonzalez-Dunia D, Brahic M. Simultaneous in situ detection of two mRNAs in the same cell using riboprobes labeled with biotin and 35S. J Histochem Cytochem 1990; 38: 917-22
35. Sessa M, Nemni R, Iannaccone S, Quattrini A, Confalonieri V, Canal N. In vivo modulation of myelin gene expression by human recombinant IL-2. Brain Res Mol Brain Res 1992; 12: 331-4
36. Brosnan CF, Selmaj K, Raine CS. Hypothesis: A role for tumor necrosis factor in immune-mediated demyelination and its relevance to multiple sclerosis. J Neuroimmunol 1988; 18: 87-94
37. Lindsley MD, Rodriguez M. Characterization of the inflammatory response in the central nervous system of mice susceptible or resistant to demyelination by Theiler’s virus. J Immunol 1989; 142: 2677-82
38. Lindsley MD, Thiemann R, Rodriguez M. Cytotoxic T cells isolated from the central nervous system of mice infected with Theiler’s virus. J Virol 1991;65: 6612-20
39. Lindsley MD, Patick AK, Prayoonwiwat N, Rodriguez M. Co-expression of class I major histocompatibility antigen and virus RNA in the central nervous system of mice infected with Theiler’s virus: A model for multiple sclerosis. Mayo Clin Proc 1992; 67: 829-38
40. Yoshioka T, Feigenbaum L, Jay G. Transgenic mouse model for central nervous system demyelination. Mol Cell Biol 1991; 11: 5479-86
41. Turnley AM, Morahan G, Okano H, et al. Dysmyelination in transgenic mice resulting from expression of class I histocompatibility molecules in oligodendrocytes. Nature 1991; 353: 566-9
42. Scherer SS, Vogelbacker HH, Kamholz J. Axons modulate the expression of proteolipid protein in the CNS. J Neurosci Res 1992; 32: 138-418
43. Kidd GJ, Hauer PE, Trapp BD. Axons modulate myelin protein messenger RNA levels during central nervous system myelination in vivo. J Neurosci Res 1990; 26: 409-18
44. McPhilemy K, Griffiths IR, Mitchell LS, Kennedy PG. Loss of axonal contact causes down-regulation of the PLP gene in oligodendrocytes; evidence from partial lesions of the optic nerve. Neuropathol Appl Neurobiol 1991; 17: 275-87
45. Prayoonwiwat N, Rodriguez M. The potential for oligodendrocyte proliferation during demyelinating disease. J Neuropathol Exp Neurol 1993; 52: 55-63